Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In recent years there have been major advances in the technology for the detection and definition of human leukocyte antigen antibodies. In this overview we describe the evolution in laboratory technology, the techniques currently available and consider their application in antibody specificity definition and in understanding a patient's sensitization profile. We discuss the importance of antibody specificity definition in facilitating efficient national organ allocation and informing clinical discussion regarding the appropriate pathway for sensitized patients awaiting renal transplantation.

Original publication

DOI

10.1097/TP.0b013e31817c90f5

Type

Journal article

Journal

Transplantation

Publication Date

15/08/2008

Volume

86

Pages

384 - 390

Keywords

Antibody Specificity, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Fluorescent Dyes, Graft Rejection, Graft Survival, HLA Antigens, Histocompatibility Testing, Humans, Immunosorbent Techniques, Isoantibodies, Kidney Transplantation, Patient Selection, Tissue and Organ Procurement